Results 181 to 190 of about 110,425 (248)
A matched case-control study on Escherichia coli factors contributing to sepsis and septic shock in bacteraemic patients. [PDF]
Commun Med (Lond)Maldonado N, López-Hernández I, Valik JK, López-Cortes LE, Martínez Pérez-Crespo PM, García-Montaner A, Alcalde-Rico M, Sousa-Domínguez A, Jover Sáenz A, Goikoetxea J, Pulido-Navazo Á, Buzón-Martín L, Aller AI, Boix-Palop L, Del Arco-Jiménez A, Smithson-Amat A, Sánchez Calvo JM, Natera-Kindelán C, Reguera Iglesias JM, Armiñanzas-Castillo C, Galán-Sánchez F, Bahamonde A, Gea-Lázaro I, Castelló-Abietar C, Pérez-Camacho I, Marrodán-Ciordia T, Becerril-Carral B, Naucler P, Pascual-Hernández Á, Rodríguez-Baño J, PROBAC REIPI/GEIRAS-SEIMC/SAMICEI Group. +30 moreeuropepmc +1 more sourceEpidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022-2024). [PDF]
Open Forum Infect DisRyan P, Berenguer J, Ramos-Ruperto L, Vera M, Martín-Carbonero L, Pérez-Latorre L, De Los Santos I, Pinto A, Vivancos MJ, Orviz E, Álvarez B, Sanz J, Ruiz-Seco P, Torres R, Brazal B, De Miguel M, López-Centeno B, Jarrín I, Resino S, Bellón JM, González-García J. +20 moreeuropepmc +1 more sourceTrends in Hepatitis C Virus Infection Prevalence Among People With HIV in Spain Over 2 Decades (2002-2023). [PDF]
Clin Infect DisBerenguer J, Fanciulli C, Arcos MM, Vivancos MJ, Domingo P, Hernando A, Barrado J, Ryan P, Navarro J, Palacios R, Morano LE, Iribarren JA, Martínez R, Galindo MJ, de Los Santos I, López-Cruz I, Rivero A, Pérez-Latorre L, Giner L, Fariñas MC, García C, Montero-Alonso M, Ferrero ÓL, Villoslada A, Soler-González JF, Sanz J, Rodríguez S, Losa JE, Bernal E, Veloso S, Pérez-Martínez L, Mateos F, Arbonés L, Franch R, Corps D, Martín C, Alonso G, Clavero-Olmos M, Silvariño R, Teira R, Belinchón O, de Miguel M, Jarrín I, González-García J. +43 moreeuropepmc +1 more sourceClinical and immunovirological status in children, adolescents and young adults with early-life-acquired HIV: a Spanish multi-cohort analysis since 2020. [PDF]
J Antimicrob ChemotherTarancon-Diez L, Lazaro-Martin B, Goicoechea-Martínez J, Domínguez-Romero R, Gómez Sirvent J, Garrote E, Minguell Domingo L, Cervantes-Hernández E, Gavilán C, Fortuny C, Bernardino JI, Diez C, Montero-Alonso M, Roca-Oporto C, Ocampo A, Jiménez AB, Rius N, López Segura N, Escosa-García L, Prieto L, Ramos JT, Navarro-Gomez ML. +21 moreeuropepmc +1 more sourceRandomized double-blind clinical trial evaluating the effectiveness and safety of secondary prophylaxis with oral vancomycin versus placebo in the prevention of recurrence of <i>clostridioides difficile</i> infection in patients receiving systemic antibiotic therapy (PREVAN trial). [PDF]
JAC Antimicrob ResistSan-Juan R, Origüen J, Fernández-Ruiz M, Campion K, Silva JT, López-Medrano F, Villa J, Díaz-Pollan B, Callejas-Díaz A, Candela G, Boan J, Aparicio-Minguijon E, Asin MAP, Rodriguez-Goncer I, Martín-Arriscado C, Ferrari JM, Aguado JM. +16 moreeuropepmc +1 more sourceHow to use novel antimicrobials beyond official indications: an expert consensus. [PDF]
JAC Antimicrob ResistRetamar-Gentil P, Alegre-Albendea M, Valiente De Santis L, Castón-Osorio JJ, Márquez-Gómez I, Corzo-Delgado JE, Praena-Segovia J, Herrero-Rodríguez C, Esteban-Moreno MÁ, Martín-Aspas A, Jiménez-Aguilar P, Martínez-Marcos FJ, López-Cárdenas S, Ojeda-Burgos G, Sadyrbaeva-Dolgova S, Anguita-Santos F, Rodríguez Baño J, Palacios-Baena ZR. +17 moreeuropepmc +1 more source